Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
8.70
Dollar change
+0.79
Percentage change
9.99
%
IndexRUT P/E- EPS (ttm)-2.68 Insider Own31.27% Shs Outstand121.11M Perf Week7.54%
Market Cap1.07B Forward P/E- EPS next Y-3.08 Insider Trans-0.05% Shs Float84.72M Perf Month27.38%
Income-325.98M PEG- EPS next Q-0.74 Inst Own78.51% Short Float / Ratio17.28% / 12.37 Perf Quarter-21.12%
Sales25.80M P/S41.57 EPS this Y-12.09% Inst Trans1.58% Short Interest14.64M Perf Half Y-24.15%
Book/sh6.32 P/B1.38 EPS next Y-6.09% ROA-31.41% Target Price23.03 Perf Year-53.18%
Cash/sh6.58 P/C1.32 EPS next 5Y- ROE-36.67% 52W Range5.95 - 23.18 Perf YTD-41.77%
Dividend- P/FCF- EPS past 5Y-47.77% ROI-39.36% 52W High-62.47% Beta1.55
Dividend %- Quick Ratio16.39 Sales past 5Y-37.69% Gross Margin80.39% 52W Low46.22% ATR0.62
Employees327 Current Ratio16.39 Sales Q/Q7226.16% Oper. Margin-1428.50% RSI (14)59.35 Volatility9.00% 8.09%
OptionableYes Debt/Eq0.07 EPS Q/Q29.14% Profit Margin-1263.49% Rel Volume1.02 Prev Close7.91
ShortableYes LT Debt/Eq0.06 EarningsNov 02 AMC Payout- Avg Volume1.18M Price8.70
Recom1.31 SMA208.78% SMA5011.72% SMA200-24.50% Volume1,204,607 Change9.99%
Date Action Analyst Rating Change Price Target Change
Apr-20-23Upgrade Jefferies Underperform → Hold $12.50
Apr-19-23Upgrade Raymond James Outperform → Strong Buy $29
Apr-13-23Initiated Raymond James Outperform $29
Feb-03-23Initiated Oppenheimer Outperform $33
Sep-30-22Initiated Barclays Equal Weight $23
Sep-02-22Initiated Stifel Buy $40
Jun-06-22Initiated Jefferies Underperform $13
Feb-01-22Initiated Berenberg Buy $45
Jul-21-21Initiated BofA Securities Buy $50
Dec-15-20Reiterated H.C. Wainwright Buy $54 → $57
Nov-30-23 09:55AM
Nov-14-23 09:55AM
Nov-07-23 04:05PM
Nov-02-23 06:21PM
04:05PM
12:00PM Loading…
Oct-31-23 12:00PM
Oct-26-23 04:05PM
10:02AM
Oct-12-23 04:05PM
Sep-18-23 04:05PM
Aug-31-23 10:16PM
Aug-08-23 06:05PM
04:02PM
Aug-01-23 04:05PM
May-25-23 05:01PM
04:05PM Loading…
May-24-23 04:05PM
May-18-23 08:16AM
May-04-23 07:25PM
04:05PM
Apr-27-23 04:05PM
10:03AM
Apr-21-23 02:48PM
Apr-20-23 02:20AM
Apr-19-23 07:30AM
Apr-18-23 10:40AM
Apr-14-23 05:05AM
Apr-13-23 06:12PM
03:49PM
Apr-07-23 07:44AM
Apr-06-23 09:55AM
07:30AM Loading…
Mar-06-23 07:30AM
Mar-01-23 07:30AM
Feb-25-23 07:31AM
Feb-23-23 05:45PM
04:05PM
Feb-21-23 10:00AM
Feb-16-23 04:05PM
10:01AM
Feb-07-23 05:01PM
Feb-02-23 07:30AM
Jan-13-23 11:11AM
Jan-03-23 07:30AM
Dec-31-22 08:53AM
Nov-24-22 08:02AM
Nov-17-22 01:58PM
Nov-07-22 07:30AM
Nov-03-22 06:35PM
04:05PM
Oct-27-22 04:05PM
Oct-14-22 10:14AM
Sep-26-22 07:30AM
Sep-23-22 07:30AM
Sep-12-22 09:30PM
07:00AM
06:30AM
Sep-11-22 09:45AM
Sep-08-22 04:06PM
10:25AM
Aug-30-22 11:15AM
Aug-25-22 02:48PM
Aug-18-22 04:05PM
Aug-04-22 04:05PM
Jul-28-22 04:05PM
Jun-27-22 06:00AM
Jun-16-22 07:30AM
May-26-22 07:30AM
May-07-22 09:59AM
May-05-22 04:05PM
May-03-22 07:30AM
Apr-28-22 04:05PM
Feb-24-22 04:05PM
Feb-17-22 04:05PM
Feb-10-22 11:51AM
Feb-02-22 07:30AM
Jan-04-22 07:30AM
Jan-03-22 07:30AM
Dec-22-21 11:11AM
Dec-18-21 12:38AM
Dec-10-21 07:30AM
Nov-17-21 11:39AM
Nov-16-21 12:36PM
Nov-10-21 04:05PM
Nov-04-21 04:05PM
08:14AM
Oct-27-21 01:23PM
04:50AM
Oct-15-21 09:01AM
Oct-12-21 09:58PM
04:27AM
Oct-11-21 04:15PM
Oct-08-21 12:24PM
06:00AM
Oct-07-21 08:50AM
Sep-13-21 06:00AM
Aug-18-21 10:27AM
Aug-15-21 04:06AM
Aug-12-21 04:05PM
Aug-05-21 04:05PM
Jul-20-21 10:48PM
Jul-19-21 09:26AM
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergstrom Donald APresident, R&DOct 30Sale6.033,45120,810235,033Nov 01 04:14 PM
Catinazzo ThomasChief Financial OfficerOct 30Sale6.031,69710,233144,145Nov 01 04:18 PM
Adams BrianChief Legal OfficerOct 30Sale6.031,6329,841129,961Nov 01 04:07 PM
Rahmer PeterSee remarksOct 30Sale6.031,3548,165316,872Nov 01 04:21 PM
Bergstrom Donald APresident, R&DSep 27Sale8.386485,430238,484Sep 29 04:52 PM
Catinazzo ThomasChief Financial OfficerSep 27Sale8.382942,464145,842Sep 29 04:22 PM
Adams BrianChief Legal OfficerSep 27Sale8.382942,464131,593Sep 29 04:10 PM
Rahmer PeterSee remarksSep 27Sale8.382442,045318,226Sep 29 04:32 PM
Bergstrom Donald APresident, R&DJul 28Sale11.802,68331,659237,904Jul 31 04:48 PM
Catinazzo ThomasChief Financial OfficerJul 28Sale11.801,69319,977146,136Jul 31 04:50 PM
Adams BrianChief Legal OfficerJul 28Sale11.801,62819,210131,887Jul 31 04:46 PM
Rahmer PeterSee remarksJul 28Sale11.801,35215,954316,808Jul 31 04:52 PM
Bergstrom Donald APresident, R&DJun 27Sale12.126477,842240,587Jun 28 05:06 PM
Adams BrianChief Legal OfficerJun 27Sale12.122943,563133,515Jun 28 05:02 PM
Catinazzo ThomasChief Financial OfficerJun 27Sale12.122943,563147,829Jun 28 05:08 PM
Rahmer PeterSee remarksJun 27Sale12.122442,957318,160Jun 28 05:12 PM
Bergstrom Donald APresident, R&DApr 28Sale11.161,38315,434242,701May 01 04:29 PM
Adams BrianChief Legal OfficerApr 28Sale11.168639,631134,882May 01 04:26 PM
Catinazzo ThomasChief Financial OfficerApr 28Sale11.168639,631149,272May 01 04:31 PM
Rahmer PeterSee remarksApr 28Sale11.167398,247157,504May 01 04:33 PM
Bergstrom Donald APresident, R&DMar 27Sale15.3676311,720244,084Mar 28 04:49 PM
Catinazzo ThomasChief Financial OfficerMar 27Sale15.363475,330150,135Mar 28 04:50 PM
Adams BrianChief Legal OfficerMar 27Sale15.363475,330135,745Mar 28 04:47 PM
Rahmer PeterSee remarksMar 27Sale15.362974,562158,243Mar 28 04:52 PM
Patel SanjivPresident and CEOFeb 09Option Exercise5.0414,00070,56014,000Feb 09 05:09 PM
Patel SanjivPresident and CEOFeb 09Sale20.5514,000287,7000Feb 09 05:09 PM
Patel SanjivPresident and CEOFeb 08Option Exercise5.0414,00070,56014,000Feb 09 05:09 PM
Patel SanjivPresident and CEOFeb 08Sale20.9814,000293,7200Feb 09 05:09 PM
Patel SanjivPresident and CEOFeb 07Option Exercise5.0414,00070,56014,000Feb 09 05:09 PM
Patel SanjivPresident and CEOFeb 07Sale21.4514,000300,3000Feb 09 05:09 PM
Bergstrom Donald APresident, R&DJan 30Sale21.561,42930,809244,847Jan 31 04:20 PM
Catinazzo ThomasChief Financial OfficerJan 30Sale21.5686418,628150,482Jan 31 04:23 PM
Adams BrianChief Legal OfficerJan 30Sale21.5686418,628136,092Jan 31 04:15 PM
Rahmer PeterSee remarksJan 30Sale21.5674015,954158,540Jan 31 04:29 PM
Patel SanjivPresident and CEOJan 19Option Exercise5.0428,000141,120282,554Jan 19 08:33 PM
Patel SanjivPresident and CEOJan 19Sale20.0228,000560,560254,554Jan 19 08:33 PM
Patel SanjivPresident and CEOJan 18Option Exercise5.0428,000141,120282,554Jan 19 08:33 PM
Patel SanjivPresident and CEOJan 18Sale20.8728,000584,360254,554Jan 19 08:33 PM
Patel SanjivPresident and CEOJan 17Option Exercise5.0428,000141,120282,554Jan 19 08:33 PM
Patel SanjivPresident and CEOJan 17Sale20.2328,000566,440254,554Jan 19 08:33 PM
Adams BrianChief Legal OfficerJan 12Sale20.009,994199,88051,531Jan 13 04:05 PM
Bergstrom Donald APresident, R&DDec 27Sale14.4998014,20085,886Dec 28 04:09 PM
Catinazzo ThomasChief Financial OfficerDec 27Sale14.494456,44850,231Dec 28 04:13 PM
Adams BrianChief Legal OfficerDec 27Sale14.492954,27561,525Dec 28 04:07 PM